Peptides, nootropics and related compounds — in English, with the limits of the evidence in plain view.

Here it is not just a gap: there is documented harm, with numbers and outcomes — and it hits exactly the people this site attracts

Where the data exist, the package insert says not to adjust anything — and the real risk sits three sections up, in an item almost nobody reads

Thirty-five times heavier than a peptide, made by a living cell and given by intravenous infusion — of the three that come up in the body-composition conversation, only one has a label

Eleven peptides, five clinical studies, zero registered trials

Out of 64,641 articles, 67 are clinical trials and 1 became a drug — and what limits that drug is not the gene editing, it is the chemotherapy around it

Eighteen treatments measured on the same yardstick: minoxidil has 23 active registrations as an anti-baldness treatment, and PP405, which circulates as a research powder, has 1 article on PubMed

The declared bottleneck is not the price — in England there are 1,794 eligible patients and 23 treatments in the first year, and the reason the assessor writes down is hospitalization, not cost

From zero to six drugs in four and a half years — and five of them were approved on a number that is not the one that matters to the patient

45,674 articles, 83 randomized trials, and no product approved by any agency

Thirteen molecules with two-digit PubMed article counts and outcome trials of up to 17,300 participants — and only one of them, inclisiran, has active registration

Seventeen candidates to delay aging: 6 don't have a single registered phase 3 trial, and 8 of the 13 active ingredients searched have no active registration

Thirteen molecules competing for semaglutide's spot — 11 already have a registered phase 3, and 9 of the 11 with a published INN have not a single active registration

13 drugs that appeared mixed in with supplements

The blend still has no trial, but three components entered clinical phase in 2026

12 phase 3 trials, published in NEJM, JAMA and Nature — and no package insert

18 imported drugs, 29 registered trials — and a forgotten history of deaths

357 articles, 7 registered trials — and a detection window of months

Fifteen molecules that peptide chatter cites as though they were equivalent to research vials — 6 of the 14 searched have active registration, with a declared commercial name and therapeutic class

Noopept, phenylpiracetam, bromantane, and cortexin together have 0 registered studies on ClinicalTrials.gov; lecanemab and donanemab already have active registration

32 with human evidence, 12 with no trial at all — and four counts that were inflated

The recombinant hormone has 54,472 articles, 183 phase 3 trials, and 9 active registrations; the secretagogues the community uses instead have zero active registrations

The doses were right. The black box warning was missing

Thymosin β-4 has 4 phase 3 trials — and they are for dry eye drops, not muscle repair; AHK-Cu has 1 article on PubMed

Half of the products sold as SARMs do not contain the SARM on the label — and four of the most popular have never had a clinical trial

The dose in the Russian trials is 12 to 72 times the community's

How many trials exist is one question; what they found is another — 34 meta-analyses opened

Russian thymic extract — 293 articles, 13 trials, zero trial registrations

Five procedures that compete with this site's vials and add up to 69,593 articles on PubMed and 5,349 registered studies

The underlying cause no liver panel sees — and one that multiplies, rather than adds to, the risk of everything else you take